glutamine has been researched along with 2-cyano-3-(1-phenylindol-3-yl)acrylate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, KS; Burgess, SC; Cox, JE; Dohlman, A; Fu, X; Gray, LR; Lane, EE; Miao, R; Norris, AW; Oonthonpan, L; Pewa, AD; Potthoff, MJ; Rauckhorst, AJ; Rutter, J; Sharma, A; Sultana, MR; Taylor, EB; Tompkins, SC; Xie, J; Zepeda-Orozco, D | 1 |
1 other study(ies) available for glutamine and 2-cyano-3-(1-phenylindol-3-yl)acrylate
Article | Year |
---|---|
Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis.
Topics: Acrylates; Animals; Cells, Cultured; Citric Acid Cycle; Diet, High-Fat; Gluconeogenesis; Glucose; Glutamine; Glycogen; Hepatocytes; Hyperglycemia; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Liver; Obesity; Proprotein Convertase 1; Proprotein Convertase 2; Pyruvic Acid; Triglycerides | 2015 |